Incyte logo

Incyte Employee Directory

Pharmaceutical ManufacturingDelaware, United States1001-5000 Employees

Incyte is a global biopharmaceutical company focused on discovering, developing, and delivering medicines for patients with unmet medical needs. Its portfolio centers on oncology and inflammatory conditions, including dermatology, with an emphasis on first-in-class therapies developed largely in-house. Headquartered in Wilmington, Delaware, the company operates across North America, Europe, and Asia and maintains a substantial, multinational workforce.
The company aims to improve patient lives by advancing therapies through science-driven discovery and development. In mid-2026, Mirum Pharmaceuticals and Incyte reported positive Phase 2 data for zilurgisertib in fibrodysplasia ossificans progressiva and noted that the FDA had begun Priority Review of the related NDA with a September 2026 decision date.

Find Incyte employees' phone numbers or email addresses

Incyte Global Highlights

Location
Employees

North America
2.9K

Minus sign iconPlus sign icon
  • United States Of America
    2.9K
  • Canada
    43
  • Mexico
    2

Europe
861

Minus sign iconPlus sign icon
  • Switzerland
    453
  • France
    89
  • Italy
    81
  • Germany
    62
  • Spain
    58
  • United Kingdom Of Great Britain And Northern Ireland
    46
  • Netherlands
    15
  • Austria
    14
  • Belgium
    13
  • Sweden
    8
  • Denmark
    6
  • Poland
    4
  • Finland
    4
  • Ukraine
    2
  • Norway
    2
  • Portugal
    2
  • Armenia
    1
  • Belarus
    1

Asia
59

Minus sign iconPlus sign icon
  • Japan
    35
  • India
    11
  • Viet Nam
    4
  • China
    4
  • Thailand
    1
  • Turkey
    1
  • Philippines
    1
  • Kazakhstan
    1
  • Indonesia
    1

South America
14

Minus sign iconPlus sign icon
  • Bolivia
    2
  • Argentina
    2
  • Chile
    2
  • Ecuador
    2
  • Brazil
    2
  • Venezuela
    2
  • Colombia
    2

Oceania
5

Minus sign iconPlus sign icon
  • Australia
    4
  • New Zealand
    1

Africa
3

Minus sign iconPlus sign icon
  • Côte D'ivoire
    1
  • South Africa
    1
  • Senegal
    1

Incyte's Leadership

  • Ceo at Incyte
    P. D.
    Ceo
  • Chief Operating Officer at Incyte
    G. G.
    Chief Operating Officer
  • Vice President Law And Compliance, International at Incyte
    R. F.
    Vice President Law And Compliance, International
  • Vice President Early Clinical Development at Incyte
    A. C.
    Vice President Early Clinical Development
  • Vp Global Quality at Incyte
    D. R.
    Vp Global Quality
  • Vice President International Quality at Incyte
    F. W.
    Vice President International Quality
  • President at Incyte
    R. E.
    President
  • President at Incyte
    R. M. B.
    President

Incyte Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Healthcare Services
  • Operations
  • Engineering
  • Business
  • Other
  • Accounting
  • Customer Success
  • Biotechnology
  • Administrative
  • Sales
  • Legal

Contact profiles from Incyte

Name
Title
Contact
Location
Last Update
  • International Vp, Head Of Hematology Oncology Unit And Business Operations at Incyte
    M. L.
    International Vp, Head Of Hematology Oncology Unit And Business Operations
    France, Île-de-France
    Aug 19, 2026
  • Vice President Law And Compliance, International at Incyte
    R. F.
    Vice President Law And Compliance, International
    Switzerland
    Jun 29, 2026
  • Head, Patient Solutions And Experience at Incyte
    M. G.
    Head, Patient Solutions And Experience
    Aug 19, 2026
  • Executive Vice President, Head Of Incyte International at Incyte
    L. H.
    Executive Vice President, Head Of Incyte International
    Switzerland, Vaud
    Sep 03, 2026
  • Executive Director - Head Of Commercial & International Marketing - Inflammation And Autoimmunity at Incyte
    A. M.
    Executive Director - Head Of Commercial & International Marketing - Inflammation And Autoimmunity
    Switzerland, Vaud
    Aug 24, 2026
  • Global Program Head at Incyte
    L. H. F.
    Global Program Head
    Japan, Tokyo
    Aug 28, 2026
  • Vp, Computational Sciences at Incyte
    M. S.
    Vp, Computational Sciences
    Aug 28, 2026
  • Senior Director, Global Clinical Operations & Head Of Regional Clinical Operations at Incyte
    A. M.
    Senior Director, Global Clinical Operations & Head Of Regional Clinical Operations
    Switzerland, Vaud
    Sep 02, 2026
  • Group Vice President, Head Of Early Clinical Development at Incyte
    E. A.
    Group Vice President, Head Of Early Clinical Development
    Switzerland, Geneva
    Sep 02, 2026
  • Senior Director Clinical Trial Head at Incyte
    T. R.
    Senior Director Clinical Trial Head
    Switzerland, Geneva
    Jul 15, 2026

Frequently Asked Questions

What is Incyte known for?

Minus sign iconPlus sign icon
Incyte operates in the Pharmaceutical Manufacturing industry. You can contact Incyte's main corporate office by phone at . Explore Incyte's company overview page for more information.

What is Incyte's most common email format?

Minus sign iconPlus sign icon
Incyte employees' email format typically follows the pattern of FLast@incyte.com. Trying to find reliable and up-to-date employee contact data? Find more Incyte email formats with LeadIQ.

How many employees does Incyte have currently?

Minus sign iconPlus sign icon
Incyte has approximately 3.5K employees as of August 2026. These team members are located across 6 continents, including North America, Europe and Asia.

Who are Incyte's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Incyte's key employees include:

  • Ceo: P. D.
  • Chief Operating Officer: G. G.
  • Vice President Law And Compliance, International: R. F.
  • Vice President Early Clinical Development: A. C.
  • Vp Global Quality: D. R.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.